Threshold Pharmaceuticals (THLD) receives FDA orphan drug designation for its TH-302 sarcoma...

|About: Threshold Pharmaceuticals... (THLD)|By:, SA News Editor

Threshold Pharmaceuticals (THLD) receives FDA orphan drug designation for its TH-302 sarcoma treatment. Shares +6.9% premarket.